1. ACTR-14. PHASE I STUDY OF AZD1775 WITH RADIATION THERAPY (RT) AND TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM) AND EVALUATION OF INTRATUMORAL DRUG DISTRIBUTION (IDD) IN PATIENTS WITH RECURRENT GBM. (5th November 2018) Authors: Alexander, Brian; Supko, Jeffrey; Agar, Nathalie; Ahluwalia, Manmeet; Desai, Arati; Dietrich, Jorg; Kaley, Thomas; Peereboom, David; Takebe, Naoko; Desideri, Serena; Fisher, Joy; Sims, Megan; Ye, Xiaobu; Ligon, Keith; Nabors, L Burt; Grossman, Stuart; Wen, Patrick Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic NF2 Mutations. Issue 3 (26th October 2022) Authors: Brastianos, Priscilla K.; Twohy, Erin L.; Gerstner, Elizabeth R.; Kaufmann, Timothy J.; Iafrate, A. John; Lennerz, Jochen; Jeyapalan, Suriya; Piccioni, David E.; Monga, Varun; Fadul, Camilo E.; Schiff, David; Taylor, Jennie W.; Chowdhary, Sajeel A.; Bettegowda, Chetan; Ansstas, George; De La Fuen... Journal: Journal of clinical oncology Issue: Volume 41:Issue 3(2023) Page Start: 618 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. ATIM-12. NEOADJUVANT ANTI-PD-1 IMMUNOTHERAPY PROMOTES INTRATUMORAL AND SYSTEMIC IMMUNE RESPONSES IN RECURRENT GLIOBLASTOMA: AN IVY CONSORTIUM TRIAL. (5th November 2018) Authors: Prins, Robert; Mochizuki, Aaron; Orpilla, Joey; Lee, Alexander; Davidson, Tom; Gaffey, Sarah; Sanders, Catherine; Rytlewski, Julie; Ellingson, Benjamin; Li, Gang; Yong, William; Clarke, Jennifer; Arrillaga-Romany, Isabel; Colman, Howard; Reardon, David; Kaley, Thomas; de Groot, John; Liau, Linda;... Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. ATIM-23. ANTI-CD27 AGONIST ANTIBODY VARLILUMAB IN COMBINATION WITH NIVOLUMAB FOR RECURRENT GLIOBLASTOMA (rGBM): PHASE 2 CLINICAL TRIAL RESULTS. (5th November 2018) Authors: Reardon, David; Kaley, Thomas; Iwamoto, Fabio; Baehring, Joachim; Subramaniam, Deepa; Rawls, Tracey; He, Yi; Keler, Tibor; Yellin, Michael Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. ATIM-38. PHASE 2 STUDY TO EVALUATE THE CLINICAL EFFICACY AND SAFETY OF MEDI4736 (DURVALUMAB, DURVA) + BEVACIZUMAB (BEV) IN BEV-NAÏVE PATIENTS WITH RECURRENT GLIOBLASTOMA (GBM). (5th November 2018) Authors: Reardon, David; Kaley, Thomas; Dietrich, Jorg; Clarke, Jennifer; Dunn, Gavin; Lim, Michael; Cloughesy, Tim; Gan, Hui; Park, Andrew; Schwarzenberger, Paul; Ricciardi, Toni; Macri, Mary; Ryan, Aileen; Venhaus, Ralph Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Bevacizumab for acute neurologic deterioration in patients with glioblastoma. (September 2013) Authors: Kaley, Thomas; Nolan, Craig; Carver, Alan; Omuro, Antonio Journal: CNS oncology Issue: Volume 2:Number 5(2013) Page Start: 413 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. CTIM-32. PHASE II AND BIOMARKER STUDY OF PEMBROLIZUMAB OR PEMBROLIZUMAB PLUS BEVACIZUMAB FOR RECURRENT GLIOBLASTOMA PATIENTS. (9th November 2020) Authors: Reardon, David; Molinaro, Annette; Peters, Katherine; Clarke, Jennifer; Jordan, Justin; de Groot, John; Nghiemphu, Phioanh; Kaley, Thomas; Colman, Howard; McCluskey, Christine; Smith, Timothy; Cote, David; Severgnini, Mariano; Yearley, Jennifer; Zhao, Qing; Blumenschein, Wendy; Duda, Gabriel; Muz... Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii40 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. CTNI-05. PRELIMINARY RESULTS OF THE NERATINIB ARM IN THE INDIVIDUALIZED SCREENING TRIAL OF INNOVATIVE GLIOBLASTOMA THERAPY (INSIGHT): A PHASE II PLATFORM TRIAL USING BAYESIAN ADAPTIVE RANDOMIZATION. (12th November 2021) Authors: Arrillaga-Romany, Isabel; Trippa, Lorenzo; Fell, Geffrey; Lee, Eudocia Quant; Rahman, Rifaquat; Touat, Mehdi; McCluskey, Christine; Bruno, Jennifer; Gaffey, Sarah; Drappatz, Jan; Lassman, Andrew; Galanis, Evanthia; Ahluwalia, Manmeet; Colman, Howard; Nabors, L Burt; Hepel, Jaroslaw; Elinzano, Hei... Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi59 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. CTNI-11. CC-115 IN NEWLY DIAGNOSED MGMT UNMETHYLATED GLIOBLASTOMA IN THE INDIVIDUALIZED SCREENING TRIAL OF INNOVATIVE GLIOBLASTOMA THERAPY (INSIGHT): A PHASE II RANDOMIZED BAYESIAN ADAPTIVE PLATFORM TRIAL. (9th November 2020) Authors: Rahman, Rifaquat; Trippa, Lorenzo; Fell, Geoffrey; Lee, Eudocia; Arrillaga-Romany, Isabel; Touat, Mehdi; McCluskey, Christine; Brunno, Jennifer; Gaffey, Sarah; Drappatz, Jan; Lassman, Andrew; Galanis, Evanthia; Ahluwalia, Manmeet; Colman, Howard; Nabors, Louis; Hepel, Jaroslaw; Elinzano, Heinrich... Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. CTNI-12. PRELIMINARY RESULTS OF THE ABEMACICLIB ARM IN THE INDIVIDUALIZED SCREENING TRIAL OF INNOVATIVE GLIOBLASTOMA THERAPY (INSIGHT): A PHASE II PLATFORM TRIAL USING BAYESIAN ADAPTIVE RANDOMIZATION. (9th November 2020) Authors: Wen, Patrick; Trippa, Lorenzo; Lee, Eudocia; Fell, Geoffrey; Rahman, Rifaquat; Arrillaga-Romany, Isabel; Touat, Mehdi; McCluskey, Christine; Brunno, Jennifer; Gaffey, Sarah; Drappatz, Jan; Lassman, Andrew; Galanis, Evanthia; Ahluwalia, Manmeet; Colman, Howard; Nabors, Louis; Hepel, Jaroslaw; Elin... Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗